Bradley Canino Stock Analyst Profile - Stifel Research Coverage - Stocknear

Bradley Canino

Stock Analyst at Stifel

(3.6)
# 2537
Out of 5,493 analysts
106
Total ratings
Success rate
Average return

22 Stocks

Name Action PT Current % Upside Ratings Updated
SNDX Syndax Pharmaceutica...
Reinstates: Buy
44
15.68 180.61% 7 Sep 10, 2025
JANX Janux Therapeutics
Reinstates: Buy
45
23.23 93.72% 3 Sep 10, 2025
BDTX Black Diamond Therap...
Maintains: Buy
16 15
3.4 341.18% 5 Mar 7, 2025
ALXO ALX Oncology Holding...
Maintains: Hold
3 2
1.87 -19.79% 8 Mar 7, 2025
CGEM Cullinan Therapeutic...
Maintains: Buy
23 19
5.96 218.79% 2 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 23
5.17 344.87% 5 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
63 51
8.27 516.69% 6 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
5 4
n/a n/a 5 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
26 19
9.05 109.94% 6 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
39 42
50.6 -17% 4 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 40
20.95 90.93% 4 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
115 135
81.39 65.87% 4 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
11.12 79.86% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
2.14 367.29% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
1.55 545.16% 17 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
90 99
68.89 43.71% 7 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
2.23 527.8% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
120 130
n/a n/a 5 Apr 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 55
56.25 -2.22% 4 Feb 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 23
n/a n/a 5 Feb 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
n/a n/a 1 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 45
n/a n/a 2 Mar 1, 2022